Bank of Montreal Can Decreases Position in HCA Healthcare, Inc. $HCA

Bank of Montreal Can cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 24.0% during the second quarter, HoldingsChannel reports. The institutional investor owned 167,664 shares of the company’s stock after selling 53,003 shares during the quarter. Bank of Montreal Can’s holdings in HCA Healthcare were worth $64,232,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. iA Global Asset Management Inc. lifted its stake in HCA Healthcare by 278.1% in the 2nd quarter. iA Global Asset Management Inc. now owns 39,928 shares of the company’s stock worth $15,296,000 after purchasing an additional 29,368 shares in the last quarter. Mission Wealth Management LP lifted its stake in HCA Healthcare by 48.4% in the 2nd quarter. Mission Wealth Management LP now owns 2,786 shares of the company’s stock worth $1,067,000 after purchasing an additional 909 shares in the last quarter. Versor Investments LP purchased a new position in HCA Healthcare in the 2nd quarter worth approximately $592,000. Syverson Strege & Co purchased a new position in HCA Healthcare in the 2nd quarter worth approximately $228,000. Finally, Creekmur Asset Management LLC increased its holdings in shares of HCA Healthcare by 31.0% during the 2nd quarter. Creekmur Asset Management LLC now owns 3,278 shares of the company’s stock worth $1,256,000 after buying an additional 775 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on HCA shares. Stephens raised their price target on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Oppenheimer raised their price target on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. Bank of America raised their price target on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. Sanford C. Bernstein reissued a “market perform” rating and issued a $417.00 target price on shares of HCA Healthcare in a research report on Monday, October 27th. Finally, The Goldman Sachs Group boosted their target price on HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a research report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Trading Up 2.1%

HCA Healthcare stock opened at $471.44 on Wednesday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $478.19. The stock’s fifty day simple moving average is $423.66 and its 200-day simple moving average is $389.09. The firm has a market capitalization of $110.31 billion, a P/E ratio of 18.22, a P/E/G ratio of 1.38 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is presently 11.13%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.